• Revenue increased 13% to A$6.77 billion
• EBITDA grew 10% to A$302.7 million
• Profit after tax up 13% to A$126.6 million

Ebos Group Ltd has reported a strong financial performance for the six months ended 31 December 2025. Revenue increased 13% to A$6.77 billion, driven by growth across the company's Healthcare and Animal Care divisions. Earnings before interest, tax, depreciation and amortisation (EBITDA) grew 10% to A$302.7 million, while profit after tax was up 13% to A$126.6 million. The company declared an interim dividend of 57 cents per share, unchanged from the prior corresponding period. Ebos' balance sheet remained robust, with equity attributable to owners of the company increasing to A$2.75 billion as at 31 December 2025. The company also completed the acquisition of SVS Group during the period, further strengthening its healthcare and animal care capabilities. Ebos remains well-positioned to deliver sustainable growth, leveraging its diversified business model and leading market positions.

Ebos expects to deliver continued growth in revenue, EBITDA and profit in the 2026 financial year, compared to the 2025 financial year.

Ebos is optimistic about the company's growth prospects, driven by ongoing expansion in its Healthcare and Animal Care divisions, as well as the successful integration of recent acquisitions. The company remains focused on delivering sustainable long-term value for shareholders.